Literature DB >> 3496984

Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK).

J S Oxford, T Corcoran, R Knott, J Bates, O Bartolomei, D Major, R W Newman, P Yates, J Robertson, R G Webster.   

Abstract

Pairs of influenza A(H1N1) viruses cultivated from the same clinical specimen in canine kidney (MDCK) cells or in embryonated hens' eggs can frequently be distinguished by their reactions with monoclonal antibodies to haemagglutinin and with antibodies in ferret or human sera. Egg-adapted virus, further passaged in MDCK cultures remained "egg-like" in serological characteristics indicating that the differences in their serological reactions were not a direct result of host cell-dependent glycosylation of the haemagglutinin. Haemagglutination-inhibiting (HI) or virus neutralizing antibodies in human sera can be detected more frequently, and to higher titre, in tests employing virus grown exclusively in MDCK cells than in tests with virus adapted to growth in embryonated eggs. Striking differences were detected in the serological reactions in HI tests when sera from ferrets infected with egg-grown virus were tested against a series of strains of influenza A(H1N1) virus isolated in 1983 and adapted to growth in eggs. In contrast, sera from ferrets infected with MDCK-derived virus failed to distinguish serologically between the same viruses that had been passaged exclusively in MDCK cells and also revealed relatively small differences between their egg-adapted counterparts.It was concluded that the cell substrate used for virus isolation and cultivation is a factor that should be considered when interpreting the results of strain characterization of influenza A(H1N1) isolates and in sero-surveys using these viruses.

Entities:  

Mesh:

Year:  1987        PMID: 3496984      PMCID: PMC2490845     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  The effect of passage in different hosts on the inhibitor sensitivity of an Asian influenza virus strain.

Authors:  A COHEN; F BIDDLE
Journal:  Virology       Date:  1960-06       Impact factor: 3.616

3.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

4.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule.

Authors:  J W Yewdell; R G Webster; W U Gerhard
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

5.  Heterogeneity of influenza B viruses.

Authors:  L Bao-Lan; R G Webster; L E Brown; K Nerome
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

6.  Sequential passage of influenza virus in embryonated eggs or tissue culture: emergence of mutants.

Authors:  C Brand; P Palese
Journal:  Virology       Date:  1980-12       Impact factor: 3.616

Review 7.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

8.  Genetic dimorphism in influenza viruses: characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties.

Authors:  E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Evidence for host-cell selection of influenza virus antigenic variants.

Authors:  G C Schild; J S Oxford; J C de Jong; R G Webster
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

  10 in total
  14 in total

1.  Failure of influenza vaccine to prevent two successive outbreaks of influenza A H1N1 in a school community.

Authors:  E L Teare; J C Rawes; P Chakraverty; N D Noah; D Webster; T Corcoran; J Oxford
Journal:  Br J Gen Pract       Date:  1990-01       Impact factor: 5.386

Review 2.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

3.  Failure-to-thrive syndrome associated with tumor formation by Madin-Darby canine kidney cells in newborn nude mice.

Authors:  Lauren R Brinster; Romelda L Omeir; Gideon S Foseh; Juliete N Macauley; Philip J Snoy; Joel J Beren; Belete Teferedegne; Keith Peden; Andrew M Lewis
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

4.  Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

Authors:  J M Katz; M Wang; R G Webster
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers.

Authors:  J S Oxford; G C Schild; T Corcoran; R Newman; D Major; J Robertson; J Bootman; P Higgins; W al-Nakib; D A Tyrrell
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Host cell-mediated selection of influenza A (H3N2) virus variant subpopulations: lack of association between antigenic and receptor-binding properties.

Authors:  R Pyhälä; L Pyhälä; P Pekkala
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

7.  Acetylated galactosamine is a receptor for the influenza C virus glycoprotein.

Authors:  P Luther; W Cushley; C Hölzer; U Desselberger; J S Oxford
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 8.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  The haemagglutinins of influenza A (H1N1) viruses in the 'O' or 'D' phases exhibit biological and antigenic differences.

Authors:  A Azzi; O Bartolomei-Corsi; K Zakrzewska; T Corcoran; R Newman; J S Robertson; P Yates; J S Oxford
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

10.  Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.

Authors:  Pirada Suphaphiphat; Lynne Whittaker; Ivna De Souza; Rodney S Daniels; Philip R Dormitzer; John W McCauley; Ethan C Settembre
Journal:  Vaccine       Date:  2016-05-21       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.